Literature DB >> 29629301

Endometriosis inflammation mimicking pseudomyxoma peritonei: A case report.

Erin E Medlin1, Claire Flanagan1, Kathryn Zavala1, Stephen Rose1.   

Abstract

Endometriosis may mimic other pathologic processes•Fertility preservation can be considered in young women with atypical endometriosis•Referral to experienced surgeons for maligancy is warranted in atypical endometriosis.

Entities:  

Year:  2016        PMID: 29629301      PMCID: PMC5885992          DOI: 10.1016/j.crwh.2016.10.005

Source DB:  PubMed          Journal:  Case Rep Womens Health        ISSN: 2214-9112


Introduction

Endometriosis is a common gynecologic condition affecting 6–10% of females and up to 50% of women with pelvic pain and/or infertility [1]. Signs and symptoms of endometriosis include dysmenorrhea, dyspareunia, dysuria, dyschezia, menorrhagia, and infertility. Common clinical findings include endometriomas, pelvic and peritoneal implants, and pelvic adhesions. Endometriosis is most often diagnosed by the presence of pelvic pain in relation to menstruation, although definitive diagnosis is made by laparoscopic identification of implants and pathologic sampling. Endometriosis may mimic other conditions, including ovarian neoplasms, ectopic pregnancy, pelvic inflammatory disease, interstitial cystitis, adenomyosis, iatrogenic pelvic adhesions, irritable bowel syndrome, colon cancer, or diverticulosis [1]. Treatment is based on severity of symptoms and the patient's reproductive plans. Treatment options include pain management, hormonal suppression, or definitive surgical management. Pseudomyxoma peritonei (PMP) is a rare condition characterized by mucinous ascites and mucinous epithelium within the peritoneal cavity, most commonly associated with gastrointestinal or primary peritoneal carcinomas of the appendix [2]. PMP is suspected if computerized tomography (CT) shows peripheral fluid collections with centralization of abdominal organs and scalloping of abdominal organs, as well as the presence of increased abdominal girth and malnutrition. Laboratory abnormalities include an elevated cancer antigen 19-9 (CA 19-9) and cancer antigen 125 (CA 125) [2]. Treatment involves surgical resection followed by hyperthermic intraperitoneal chemotherapy (HIPEC). We present a case of a young women with endometriosis whose clinical presentation was consistent with PMP.

Case Report

A 25 year-old nulliparous female presented to her primary care physician with three months of diffuse abdominal pain and a 30-pound weight gain. Her medical history was significant for migraines, depression, and idiopathic hemolytic anemia requiring transfusion in 2011. Family history was significant for a brother with leukemia. She had normal menstrual cycles, no dyspareunia or dysmenorrhea, and no change in bowel habits. She did later endorse occasional abdominal pain and brief, monthly episodes of epistaxis. On exam, her abdomen was protuberant with a positive fluid wave. Pelvic exam was limited by ascites but revealed a mobile, non-tender cervix without nodularity, a normal-sized, anteverted uterus, and no palpable pelvic masses. A urine pregnancy test was negative. CT scan revealed multi-loculated, multi-septated, low attenuation fluid filling the abdomen and pelvis and a 4.5 × 6.7 × 6 cm left adnexal mass (Fig. 1). The patient was referred to a gynecologic oncologist for further management.
Fig. 1

CT images at presentation demonstrating multi-sepatated, low attenuation fluid with centralization of the bowel.

CT images at presentation demonstrating multi-sepatated, low attenuation fluid with centralization of the bowel. Further studies included a complete blood count and chemistries, which were normal. CA-125 was elevated at 223. Imaging was concerning for pseudomyxoma peritonei given findings of the multi-septated fluid collections and bowel centralization.

Procedure

The patient was referred to gynecologic oncology for surgical intervention. An exploratory laparotomy was recommended for pelvic mass resection, fluid drainage, and possible hysterectomy, bilateral salingoophorectomy, bowel resection, appendectomy, and intraoperative hyperthermic intraperitoneal chemotherapy. Fertility preservation was desired. She underwent an exploratory laparotomy, removal of loculated ascites, removal of peritoneal endometriotic implants, and ovarian preservation. Intraoperative findings were significant for large, cystic masses filling the abdominal cavity. However, these appeared to arise from the peritoneum rather than ovary or bowel and had no definitive blood supply. Additionally, adhesions and endometriomas were noted in the pelvis, especially the posterior cul-de-sac, and were carefully dissected from the peritoneum. Ovaries and uterus were without masses and were preserved. Appendectomy and omentectomy were performed, but bowel resection and chemotherapy were not indicated given the intraoperative findings. Final pathology revealed a 30 cm mucicarmine and calretinin negative, WT-1 +/CD10 +/PR + serous cystadenoma with endometriosis. The patient had an uncomplicated postoperative course and was discharged home on postoperative day three with a prescription for an oral contraceptive (Fig. 2).
Fig. 2

Histologic images from cystic tissue featuring endometrioid gland with cilia and characteristic hemosiderin deposits (2a), as well as stroma with hyperemic blood vessels (2b).

Histologic images from cystic tissue featuring endometrioid gland with cilia and characteristic hemosiderin deposits (2a), as well as stroma with hyperemic blood vessels (2b).

Discussion

The novelty of this case lies in the common features and dramatic differences in management between pseudomyxoma peritonei, an uncommon finding that portends malignancy, and endometriosis, which affects > 175 million women worldwide [3]. Moreover, the finding of a serous cystadenoma is thought to have arisen from preexisting endometriosis. While endometriosis more commonly presents as isolated, superficial implants < 5 cm in aggregate, a review of the literature has identified four case reports of endometriosis presenting as large, cystic endometriomas [4], [5], [6], [7]. Endometriosis presenting alongside frank ascites is evident in the literature as well; however, this is more commonly confused with Meigs syndrome than pseudomyxoma peritonei [8], [9]. An increasing body of evidence that endometriosis is associated with a chronic inflammatory state, increased cyclooxygenase-2 activity, elevated activated macrophages, and proinflammatory cytokines suggests that fluid extravasation and edema is an expected albeit atypical finding in endometriosis [3], [10]. This case highlights that endometriosis should be part of any differential diagnosis for premenopausal patients presenting with a complex pelvic fluid collection.
  10 in total

Review 1.  Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis.

Authors:  Rafet Gazvani; Allan Templeton
Journal:  Reproduction       Date:  2002-02       Impact factor: 3.906

Review 2.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

Review 3.  Pseudomyxoma peritonei.

Authors:  Robert M Smeenk; Sjoerd C Bruin; Marie-Louise F van Velthuysen; Victor J Verwaal
Journal:  Curr Probl Surg       Date:  2008-08       Impact factor: 1.909

4.  Endometriosis with myxoid change mimicking pseudomyxoma peritonei.

Authors:  Kenneth Tang; Stephen Lyons; Susan Valmadre; Peter Russell
Journal:  Pathology       Date:  2010-01       Impact factor: 5.306

5.  Widespread endometriosis mimicking ovarian malignancy: a case report.

Authors:  R A Akinola; O I Akinola; A Alakija; K O Wright
Journal:  Niger Postgrad Med J       Date:  2012-03

6.  Massive peritoneal fluid and markedly elevated serum CA125 and CA19-9 levels associated with an ovarian endometrioma.

Authors:  Byung-Joon Park; Tae-Eung Kim; Yong-Wook Kim
Journal:  J Obstet Gynaecol Res       Date:  2009-10       Impact factor: 1.730

Review 7.  A systematic review: endometriosis presenting with ascites.

Authors:  Tayfun Gungor; Mine Kanat-Pektas; Mustafa Ozat; Mujdegul Zayifoglu Karaca
Journal:  Arch Gynecol Obstet       Date:  2010-09-07       Impact factor: 2.344

Review 8.  Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis.

Authors:  Fernando M Reis; Felice Petraglia; Robert N Taylor
Journal:  Hum Reprod Update       Date:  2013-03-28       Impact factor: 15.610

Review 9.  Near lethal endometriosis and a massive (64 kg) endometrioma: case report and review of the literature.

Authors:  S V Sakpal; C Patel; R S Chamberlain
Journal:  Clin Exp Obstet Gynecol       Date:  2009       Impact factor: 0.146

10.  Pelvic endometriosis mimicking advanced ovarian cancer: presentation with pleural effusion, ascites, and elevated serum CA 125 level.

Authors:  T J Myers; B Arena; C O Granai
Journal:  Am J Obstet Gynecol       Date:  1995-09       Impact factor: 8.661

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.